Haylard BASIC BIOPSY TRAY; Model/Item Number (Kit): PM415; Recall
Haylard BASIC BIOPSY TRAY; Model/Item Number (Kit): PM415;
FDA recall Class I
Ongoing
FDA lists this Class I recall for Haylard BASIC BIOPSY TRAY; Model/Item Number (Kit): PM415;. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-3153-2026
- Recall classification
- Class I
- Enforcement status
- Ongoing
- Initiation date
- Aug 10, 2026
- FDA report date
- Sep 23, 2026
- Quantity in commerce
- 240 kits
- Distribution
- See key details
- FDA cause
- Nonconforming Material/Component
What is being recalled?
Haylard BASIC BIOPSY TRAY; Model/Item Number (Kit): PM415;
Affected model & UDI checker
Search the exact identifiers published for Z-3153-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | Haylard BASIC BIOPSY TRAY; Model/Item Number (Kit): PM415; | Check source notice | 10809160322154 |
FDA code information
Model/Item Number (Kit): PM415; UDI-DI: 10809160322154; Kit Lots: 1652485, 1656642, 1667835, 1676219, 1682251, 1691940; Recalled Sodium Chloride Ampule Lot: AB5002, AB4003;
Why was this product recalled?
Potential for product quality and sterility issues regarding kits containing Sodium Chloride ampules subject to recall by Spectra Medical.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did AVID Medical, Inc. take?
On August 10, 2026 URGENT: MEDICAL DEVICE RECALL letters were sent to customers. Actions to be taken: 1. Identify, Segregate, and Quarantine all impacted kits listed. 2. Add warning labels to affected kits to ensure all users are aware of the actions to take prior to use. A labeling template is enclosed for printing labels which can be affixed on all affected kits and cases in inventory. This label should be applied in a prominently visible location to end-users. The location chosen should not cover any other critical product information found on existing product labeling. If pre-printed labels are needed, please contact your sales representative. 3. REMOVE AND DISCARD the Sodium Chloride, 0.9%, USP 10 mL Flush ampules prior to use. 4. Customers (end-users): If you have received product from a distributor, please contact the distributor or your sales representative with any questions you may have. 5. Distributors: If any of the affected kits identified above were further distributed, please ensure all end-users are appropriately notified and maintain records of effectiveness. 6. Complete the attached Recall Response Form and return.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-3153-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 20, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 20, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology